Lauren Pischel, MD, MSc

• Akiko Iwasaki
• Albert Ko
• Alfred Lee
• Anjelica Martin
• Christina Price
• Clemente Britto-Leon
• Cynthia Frary McNamara
• Frederick Lewis Altice
• George Goshua
• Inci Yildirim
• Jessica Tuan
• Kavin Patel
• Kelsey Kaman
• Lydia Aoun-Barakat
• Maricar Malinis
• Marwan Mikheal Azar
• Matthew Grant
• Merceditas Villanueva
• Mitermayer Reis
• Onyema Ogbuagu
• Rebecca Slotkin
• Richard A Martinello
• Saad B. Omer
• Shaili Gupta
• Stuart Seropian
• Tassos C. Kyriakides
• Xuchen Zhang

Emerging Infectious Diseases; Global Health; Climate Change; Vaccines

• Characterizing healthcare worker attitudes toward the bivalent COVID-19 boosterWillebrand K, Fredrick J, Pischel L, Patel K, Roberts S, Murray T, Martinello R. Characterizing healthcare worker attitudes toward the bivalent COVID-19 booster. Antimicrobial Stewardship & Healthcare Epidemiology 2023, 3: s56-s57. PMCID: PMC10594485, DOI: 10.1017/ash.2023.300.
• Serum Neutralizing Antibody Titers 12 Months After COVID-19 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US PopulationZhao M, Slotkin R, Sheth AH, Pischel L, Kyriakides TC, Emu B, McNamara C, Shi Q, Delgobbo J, Xu J, Marhoffer E, Mercer-Falkoff A, Holleck J, Ardito D, Sutton RE, Gupta S. Serum Neutralizing Antibody Titers 12 Months After COVID-19 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population. Clinical Infectious Diseases 2022, 76: ciac416. PMID: 35639598, PMCID: PMC9278145, DOI: 10.1093/cid/ciac416.
• Rainfall and other meteorological factors as drivers of urban transmission of leptospirosisCunha M, Costa F, Ribeiro GS, Carvalho MS, Reis RB, Nery N, Pischel L, Gouveia EL, Santos AC, Queiroz A, Wunder EA, Reis MG, Diggle PJ, Ko AI. Rainfall and other meteorological factors as drivers of urban transmission of leptospirosis. PLOS Neglected Tropical Diseases 2022, 16: e0007507. PMID: 35404948, PMCID: PMC9022820, DOI: 10.1371/journal.pntd.0007507.
• Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopeniaGoshua G, Sinha P, Kunst N, Pischel L, Lee AI, Cuker A. Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia. American Journal Of Hematology 2022, 98: 122-130. PMID: 35147241, PMCID: PMC9365880, DOI: 10.1002/ajh.26497.
• Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysisPischel L, Patel KM, Goshua G, Omer SB. Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2022, 75: 1179-1186. PMID: 35134164, PMCID: PMC9383370, DOI: 10.1093/cid/ciac080.
• A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020Willebrand KS, Pischel L, Malik AA, Jenness SM, Omer SB. A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020. Eurosurveillance 2022, 27: 2002113. PMID: 34991781, PMCID: PMC8739343, DOI: 10.2807/1560-7917.es.2022.27.1.2002113.
• 386. A Systematic Review of COVID-19 Transmission Dynamics and Clinical Response on Cruise Ships Globally Between January and October 2020Willebrand K, Pischel L, Malik A, Jenness S, Omer S. 386. A Systematic Review of COVID-19 Transmission Dynamics and Clinical Response on Cruise Ships Globally Between January and October 2020. Open Forum Infectious Diseases 2021, 8: s294-s295. PMCID: PMC8644941, DOI: 10.1093/ofid/ofab466.587.
• 572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective CohortVahidy F, Pischel L, Tano M, Pan A, Boom M, Sostman H, Nasir K, Omer S. 572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective Cohort. Open Forum Infectious Diseases 2021, 8: s388-s388. PMCID: PMC8644874, DOI: 10.1093/ofid/ofab466.770.
• High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19Haynes WA, Kamath K, Bozekowski J, Baum-Jones E, Campbell M, Casanovas-Massana A, Daugherty PS, Dela Cruz CS, Dhal A, Farhadian SF, Fitzgibbons L, Fournier J, Jhatro M, Jordan G, Klein J, Lucas C, Kessler D, Luchsinger LL, Martinez B, Catherine Muenker M, Pischel L, Reifert J, Sawyer JR, Waitz R, Wunder EA, Zhang M, Iwasaki A, Ko A, Shon J. High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19. Communications Biology 2021, 4: 1317. PMID: 34811480, PMCID: PMC8608966, DOI: 10.1038/s42003-021-02835-2.
• Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune ThrombocytopeniaGoshua G, Sinha P, Pischel L, Lee A, Cuker A. Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia. Blood 2021, 138: 751. DOI: 10.1182/blood-2021-144819.
• Strategies to increase uptake of maternal pertussis vaccinationPatel KM, Guillamet L, Pischel L, Ellingson MK, Bardají A, Omer SB. Strategies to increase uptake of maternal pertussis vaccination. Expert Review Of Vaccines 2021, 20: 779-796. PMID: 34129416, PMCID: PMC9288655, DOI: 10.1080/14760584.2021.1940146.
• A Brewing Back PainPischel L, Geirsson A, Magaldi J, Martinello RA, Lee AI. A Brewing Back Pain. New England Journal Of Medicine 2021, 385: 66-72. PMID: 34192434, PMCID: PMC9273048, DOI: 10.1056/nejmcps2034802.
• Bartonellosis in transplant recipients: A retrospective single center experiencePischel L, Radcliffe C, Vilchez GA, Charifa A, Zhang XC, Grant M. Bartonellosis in transplant recipients: A retrospective single center experience. World Journal Of Transplantation 2021, 11: 244-253. PMID: 34164299, PMCID: PMC8218350, DOI: 10.5500/wjt.v11.i6.244.
• Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to seePischel L, Goshua G. Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see. Clinical Infectious Diseases 2021, 73: ciab459-. PMID: 33999992, PMCID: PMC8194546, DOI: 10.1093/cid/ciab459.
• Race and ethnicity do not impact eligibility for remdesivir: A single-center experiencePischel L, Walelo M, Benson J, Osborn R, Schrier R, Tuan J, Barakat L, Ogbuagu O. Race and ethnicity do not impact eligibility for remdesivir: A single-center experience. PLOS ONE 2021, 16: e0250735. PMID: 33956849, PMCID: PMC8101938, DOI: 10.1371/journal.pone.0250735.
• Fast Development of High-Quality Vaccines in a PandemicPischel L, Yildirim I, Omer SB. Fast Development of High-Quality Vaccines in a Pandemic. CHEST Journal 2021, 160: e1-e3. PMID: 33848535, PMCID: PMC8102080, DOI: 10.1016/j.chest.2021.03.063.
• Improving diagnosis by feedback and deliberate practice: one-on-one coaching for diagnostic maturationSinha P, Pischel L, Sofair AN. Improving diagnosis by feedback and deliberate practice: one-on-one coaching for diagnostic maturation. Diagnosis 2021, 8: 157-160. PMID: 33544476, PMCID: PMC9256033, DOI: 10.1515/dx-2020-0129.
• Diagnosis of oesophageal mucormycosis managed with medical therapy aloneRinger M, Pischel L, Azar MM. Diagnosis of oesophageal mucormycosis managed with medical therapy alone. BMJ Case Reports 2020, 13: e236869. PMID: 33093060, PMCID: PMC7583061, DOI: 10.1136/bcr-2020-236869.
• Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical OutcomesPrice CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes. CHEST Journal 2020, 158: 1397-1408. PMID: 32553536, PMCID: PMC7831876, DOI: 10.1016/j.chest.2020.06.006.
• The Letter.Pischel L. The Letter. Annals Of Internal Medicine 2018, 169: 126. PMID: 30014110, DOI: 10.7326/M18-0627.
• Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention.Ley C, Pischel L, Parsonnet J. Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention. Reproductive Toxicology (Elmsford, N.Y.) 2017, 74: 143-149. PMID: 28939492, PMCID: PMC5718922, DOI: 10.1016/j.reprotox.2017.09.005.
• Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome.Poole AC, Pischel L, Ley C, Suh G, Goodrich JK, Haggerty TD, Ley RE, Parsonnet J. Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome. MSphere 2016, 1 PMID: 27303746, PMCID: PMC4888890, DOI: 10.1128/mSphere.00056-15.
• Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew.Rizal RE, Mediratta RP, Xie J, Kambhampati S, Hills-Evans K, Montacute T, Zhang M, Zaw C, He J, Sanchez M, Pischel L. Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew. Advances In Medical Education And Practice 2015, 6: 471-7. PMID: 26170731, PMCID: PMC4492543, DOI: 10.2147/AMEP.S70294.
• Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.Raj DK, Nixon CP, Nixon CE, Dvorin JD, DiPetrillo CG, Pond-Tor S, Wu HW, Jolly G, Pischel L, Lu A, Michelow IC, Cheng L, Conteh S, McDonald EA, Absalon S, Holte SE, Friedman JF, Fried M, Duffy PE, Kurtis JD. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science (New York, N.Y.) 2014, 344: 871-7. PMID: 24855263, PMCID: PMC4184151, DOI: 10.1126/science.1254417.